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Nationwide study in France 
investigating the impact 
of diabetes on mortality in patients 
undergoing abdominal aortic 
aneurysm repair
Juliette Raffort1,2*, Fabien Lareyre3, Roxane Fabre4, Ziad Mallat5, Christian Pradier6 & 
Laurent Bailly6
The aim of this nationwide study was to analyze the impact of diabetes on post-operative mortality in 
patients undergoing AAA repair in France. This 10-year retrospective, multicenter study based on the 
French National electronic health data included patients undergoing AAA repair between 2010 and 
2019. In-hospital post-operative mortality was analyzed using Kaplan–Meier curve survival and Log-
Rank tests. A multivariate regression analysis was performed to calculate Hazard Ratios. Over 79,935 
patients who underwent AAA repair, 61,146 patients (76.5%) had at least one hospital-readmission 
after the AAA repair, for a mean follow-up of 3.5 ± 2.5 years. Total in-hospital mortality over the 
10-year study was 16,986 (21.3%) and 4581 deaths (5.8%) occurred during the first hospital stay for 
AAA repair. Age over 64 years old, the presence of AAA rupture and hospital readmission at 30-day 
were predictors of post-operative mortality (AdjHR = 1.59 CI 95% 1.51–1.67; AdjHR = 1.49 CI 95% 
1.36–1.62 and AdjHR = 1.92, CI 95% 1.84–2.00). The prevalence of diabetes was significantly lower in 
ruptured AAA compared to unruptured AAA (14.8% vs 20.9%, P < 0.001 for type 2 diabetes and 2.5% vs 
4.0%, P < 0.001 for type 1 diabetes). Type 1 diabetes was significantly associated with post-operative 
mortality (AdjHR = 1.30 CI 95% 1.20–1.40). For type 2 diabetes, the association was not statistically 
significant (Adj HR = 0.96, CI 95% 0.92–1.01). Older age, AAA rupture and hospital readmission were 
associated with deaths that occurred after discharge from the first AAA repair. Type 1 diabetes was 
identified as a risk factor of post-operative mortality. This study highlights the complex association 
between diabetes and AAA and should encourage institutions to report long-term follow-up after AAA 
repair to better understand its impact.
Cardiovascular diseases are the leading cause of premature death in developed  countries1. Among them, abdomi-
nal aortic aneurysm (AAA), defined as a focal dilatation of the aorta, has become a significant public health 
challenge worldwide, with extremely high rates of mortality in case of  rupture2–4. Its prevalence in European 
countries has been estimated between 1.3 to 3.3% of men over 65 years and 0.7% of women over 60  years2,5. 
The treatment of AAA relies on surgical approaches and can be performed using open repair or endovascular 
aneurysm repair (EVAR)2,4,6.
AAA is often associated with atherosclerosis and cardiovascular risk factors such as age, male sex, tobacco 
use, hypertension or obesity {Wanhainen, 2019 #4}{Kent, 2010 #67}. Intriguingly, epidemiological studies have 
pointed to a negative association between diabetes and AAA 7. Diabetic patients develop smaller aneurysm 
compared to non-diabetic  subjects8,9. The prevalence, the incidence, the aneurysmal growth as well as the risk of 
rupture is lower in diabetic  patients8,10–12. While diabetes may play a protective role on aneurysm  development7, 
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its effect on the post-operative outcomes in patients undergoing AAA repair is more controversial and is not 
well-established13–18.
A better understanding of the impact of diabetes on the outcomes of patients undergoing AAA repair would 
help to improve their management and anticipate post-operative complications.
In this 10-year descriptive nationwide study, we aimed to explore the association between diabetes and post-
operative mortality in patients undergoing AAA repair in France.
Methods
Study design and data collection. This population-based, multicenter, cohort study was based on 
the French National Health insurance information system and was conducted in accordance with the French 
National Health Data Institute regulation (Institut National des Données de Santé, INDS). The protocol was 
approved by the Institutional Review Board of the University Hospital of Nice and by the French National Health 
Information System (Système National des Données de Santé, SNDS). This electronic database has been previ-
ously  described19,20 and informed consent was waived for this type of study in accordance with the French 
National Health Data Institute regulation. Information was extracted from anonymous discharge reports com-
pleted and coded at the end of each hospital stay.
Eligible patients where those undergoing an AAA repair for the first time in any public or private hospital 
in France between 2010 and 2019. AAA repair was classified into open repair or EVAR according to the Com-
mon Classification of Medical Acts (CCAM). Collected data included the general characteristics of patients, 
the comorbidities, the type of AAA repair, the presence of an aneurysm rupture or not, and the post-operative 
outcomes (mortality and in-hospital readmission at 30 days). Comorbidities were defined according to the 
International Classification of Diseases (ICD-10). The codes used are presented in the Supplementary data.
The all-cause mortality was analyzed based on the French National electronic health data that allowed to 
identify all deaths registered during a hospital stay over a ten-year period. The in-hospital mortality during the 
first AAA repair was analyzed. Hospital readmission at 30 days included all re-hospitalization occurring within 
30 days after discharge from the first AAA repair whatever the cause. For the follow-up, patients who had at least 
one re-admission at hospital after the first AAA repair recorded in the National French electronic health data were 
included. In-hospital total mortality was defined as the number of deaths during hospital stay recorded from the 
first AAA repair until the last follow-up. The French National Health Information System only had access and 
recorded deaths occurring during a hospital stay. The analysis thus excluded deaths occurring out of hospital.
Statistical analysis. Results for quantitative variables were expressed as means ± standard deviation (SD) 
and as percentages for categorical variables. Group differences were analyzed using Student t-test for quantitative 
variables and Chi-2 test or Fisher test for qualitative variables.
A survival analysis was performed in order to identify risk factors associated with post-operative mortal-
ity. Only patients who had at least one follow-up at hospital after the first AAA repair recorded in the National 
French electronic health data between 2010 and 2019 were included. The release date from the hospital after the 
first AAA repair was considered as the starting point and the follow-up was calculated from this date until the 
last hospital stay. The analysis excluded deaths that occurred during the hospital stay for the first AAA repair. 
Kaplan–Meier curve survival and Log-Rank tests were used to analyze the risk of post-operative mortality. 
Multivariate regression analysis using a Cox proportional model was performed to calculate Hazard Ratios with 
95% CI. The hypothesis of the proportional risk was evaluated according to the survival curves using the double 
negative logarithm function. The factors which did not comply with the hypothesis of the proportional risk 
were excluded from the model. A two-tailed P-value < 0.05 was considered as statistically significant. Statistical 
analysis was performed using SAS Enterprise 5.1 (SAS Institute, Cary, NC).
Ethical approval for research. The study was conducted in accordance with the French National Health 
Data Institute regulation.
Results
Characteristics of patients who underwent AAA repair in France between 2010 and 
2019. Between 2010 and 2019, 79,935 patients underwent AAA repair in France and were included in this 
study; 31,041 (38.8%) had an open repair while 48,894 (61.2%) underwent EVAR. The flow chart of the study 
population is depicted in Fig.  1. The mean age of the population was 71.6 ± 9.7  years and 90.6% were men 
(Table 1). The in-hospital death during the first AAA repair was 4581 (5.8%). The total of in-hospital death over 
the 10-year study was 16,986 (21.3%). It included deaths registered at the hospital from the first AAA repair until 
the last follow-up.
In 94.1% of cases, the AAA was not ruptured (n = 75,257), while ruptured aneurysms concerned less than 
6% of patients (n = 4678; 5.9%). Most of the patients with ruptured AAA were treated using open repair (4531 
out of 4678, 96.8%). The total in-hospital mortality was significantly higher in patients with AAA rupture (2425, 
51.8%) compared to those without rupture (14,561, 19.4%, P < 0.001). The in-hospital mortality during the first 
hospital stay for AAA repair was significantly higher in patients who had open repair compared to those who 
underwent EVAR (10.7% vs 2.6%, P < 0.001). In case of AAA rupture, the death occurred more frequently during 
the hospital stay of the first AAA repair (1873 out of 2425, 77.2%) while it represented only 18.7% (2708 out of 
14,561) of the total deaths in patients without rupture.
The prevalence of type 2 diabetes was 16,408 patients (20.5%) and 3092 patients (3.9%) for type 1 diabe-
tes. The prevalence of followed comorbidities was significantly lower in patients with AAA rupture compared 
to those without rupture. This included type 2 diabetes (14.8% vs 20.9%, P < 0.001), type 1 diabetes (2.5% vs 
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4.0%, P < 0.001), arterial hypertension (65.1%, vs 76.9%, P < 0.001), dyslipidemia (31.7% vs 52.5%, P < 0.001), 
obesity (17.2% vs 22.2%, P < 0.001) or obstructive sleep apnea (6.4% vs 10.8%, P < 0.001). The prevalence of 
known cardiovascular risk factors and followed diseases was also lower, with a lower rate of smoking (21.1% vs 
24.2%, P < 0.001), congestive heart failure (29.1% vs 36.1%, P < 0.001) or past history of stroke (13.3% vs 19.1%, 
P < 0.001).
Association between diabetes and post-operative mortality of patients who underwent AAA 
repair. Post-operative mortality after AAA repair was compared between diabetic and non-diabetic patients 
and was analyzed according to the surgical technique and the presence or absence of rupture (Table  2). In 
patients undergoing AAA open repair, the in-hospital mortality during the first AAA repair was significantly 
lower in diabetic patients compared to non-diabetic (4.5% vs 5.8%, p < 0.01 for unruptured AAA and 32.1% vs 
42.6%, p < 0.01 for ruptured AAA). However, the total in-hospital mortality was significantly higher in diabetic 
Figure 1.  Flow chart of the study population. Data are expressed as n (%).
Table 1.  Characteristics of patients operated for an abdominal aortic aneurysm classified according to the 
type of surgery and the presence of a rupture. Results are expressed as mean ± SD or n (%). AAA abdominal 
aortic aneurysm, CHF congestive heart failure, d days, EVAR endovascular aneurysm repair, F female, M male, 






N = 48,894 p
Non ruptured AAA 
N = 75,257
Ruptured AAA 
N = 4678 p
Agey 71.6 ± 9.7 68.7 ± 9.3 73.4 ± 9.1  < 0.001 71.6 ± 9.7 72.1 ± 10.4  < 0.001
Sex ratio M/F (%) 90.6/9.4 90.8/9.2 90.4/9.6 0.09 90.7/9.3 88.8/11.2  < 0.001
In-hospital  stayd 10.0 ± 11.1 13.9 ± 13.9 7.5 ± 7.9  < 0.001 9.7 ± 10.2 15.5 ± 20.0  < 0.001
Rupture 4678 (5.9) 4531 (14.6) 147 (0.3)  < 0.001
In-hospital death during 
the first AAA repair 4581 (5.8) 3324 (10.7) 1257 (2.6)  < 0.001 2708 (3.6) 1873 (40.0)  < 0.001
In-hospital total death 16,986 (21.3) 7143 (23.0) 9843 (20.1)  < 0.001 14,561 (19.4) 2425 (51.8)  < 0.001
Arterial hypertension 60,897 (76.2) 23,283 (75.0) 37,614 (76.9)  < 0.001 57,853 (76.9) 3044 (65.1)  < 0.001
Dyslipidemia 40,989 (51.3) 15,895 (51.2) 25,094 (51.3) 0.75 39,504 (52.5) 1485 (31.7)  < 0.001
T2D 16,408 (20.5) 5931 (19.1) 10,477 (21.4)  < 0.001 15,718 (20.9) 690 (14.8)  < 0.001
T1D 3092 (3.9) 1049 (3.4) 2043 (4.2)  < 0.001 2973 (4.0) 119 (2.5)  < 0.001
Smoking 19,225 (24.1) 8964 (28.9) 10,261 (21.0)  < 0.001 18,238 (24.2) 987 (21.1)  < 0.001
Obesity 17,541 (21.9) 6352 (20.5) 11,189 (22.9)  < 0.001 16,738 (22.2) 803 (17.2)  < 0.001
Obstructive sleep apnea 8403 (10.5) 2769 (8.9) 5634 (11.5)  < 0.001 8105 (10.8) 298 (6.4)  < 0.001
CHF 28,499 (35.7) 10,170 (32.8) 18,329 (37.5)  < 0.001 27,138 (36.1) 1361 (29.1)  < 0.001
Chronic respiratory 
disease 23,096 (28.9) 9075 (29.2) 14,021 (28.7) 0.09 22,051 (29.3) 1045 (22.3)  < 0.001
Chronic kidney disease 16,332 (20.4) 5561 (17.2) 10,771 (22.0)  < 0.001 15,487 (20.6) 845 (18.1)  < 0.001
Stroke 14,959 (18.7) 2394 (7.7) 4403 (9.0)  < 0.001 14,337 (19.1) 622 (13.3)  < 0.001
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patients compared to non-diabetic after open repair for unruptured AAA (20.5% vs 17.5, p < 0.01). In case of 
ruptured AAA treated with open repair, diabetic patients had lower total in-hospital mortality (47.4% vs 52.5%, 
p < 0.05). For patients undergoing EVAR, no significant difference was observed for in-hospital death during the 
first AAA repair. The in-hospital total mortality was higher in diabetic patients after treatment of unruptured 
AAA (21.9% vs 19.5%, p < 0.01) while there was no significant difference for ruptured AAA.
Factors associated with post-operative mortality after AAA repair. In total, 61,146 patients 
(76.5%) had at least one follow-up after the release date from the first AAA repair and were included in the 
analysis (Fig. 1). The mean follow-up was 3.5 years± 2.5. A multivariate analysis was performed to identify risk 
factors of post-operative mortality. The analysis excluded in-hospital mortality during the first AAA repair. The 
total of in-hospital deaths that occurred after the first AAA repair was 12,400 (20.3%) including 3817 deaths 
after open repair and 8583 deaths after EVAR. Age over 64 years old and the presence of AAA rupture were 
positively associated with the risk of in-hospital post-operative total mortality (AdjHR = 1.59 CI95% = 1.51–1.67 
and AdjHR = 1.49 CI95% = 1.36–1.62) (Table  3). In-hospital readmission at 30-day was a strong predictor of 
in-hospital post-operative mortality (AdjHR = 1.92, CI95% = 1.84–2.00). Compared to open repair, EVAR was 
associated with increased risk of in-hospital post-operative mortality (AdjHR = 1.48, CI95% 1.42–1.54). Among 
cardiovascular diseases, congestive heart failure and history of stroke were significantly associated with the risk 
of in-hospital post-operative mortality (Adj HR. = 1.40, CI95% = 1.35–1.46 and AdjHR = 1.19, CI95% = 1.14–
1.23, respectively). Other comorbidities such as chronic respiratory disease or chronic kidney disease were also 
predictive of in-hospital post-operative mortality. Type 1 diabetes was positively associated with the risk of post-
operative mortality (AdjHR = 1.30, CI95% = 1.20–1.40). For type 2 diabetes, the association was not statistically 
significant (Adj HR = 0.96, CI95% = 0.92–1.01).
Table 2.  Post-operative mortality of patients with and without diabetes who underwent abdominal aortic 
aneurysm repair according to surgical technic and presence or absence of ruptured AAA. * Endovascular 
aneurysm repair ** Fisher exact Test. AAA abdominal aortic aneurysm.
Open repair EVAR*
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Table 3.  Risk factors of in-hospital mortality after abdominal aortic aneurysm surgical repair. *Population 
of patients who had at least one follow-up i.e. admission at the hospital after the AAA surgical repair. Results 
are expressed as mean ± SD or n (%). AAA abdominal aortic aneurysm, CHF congestive heart failure, EVAR 







Adjusted hazard ratio CI 95% Adjusted hazard ratio CI 95% Adjusted hazard ratio CI 95%
In-hospital readmission 
at 30 days 1.92 1.84–2.00 2.03 1.88–2.19 1.88 1.79–1.98
Age > 64 years 1.59 1.51–1.67 1.53 1.42–1.65 1.63 1.52–1.74
Ruptured AAA 1.49 1.36–1.62 1.48 1.34–1.63 1.60 1.26–2.02
EVAR (ref. open repair) 1.48 1.42–1.54
CHF 1.40 1.35–1.46 1.33 1.24–1.42 1.44 1.38–1.51
Chronic respiratory 
disease 1.33 1.28–1.38 1.35 1.26–1.45 1.32 1.26–1.38
Chronic kidney disease 1.31 1.26–1.36 1.30 1.21–1.39 1.31 1.25 -1.37
T1D 1.30 1.20–1.40 1.33 1.16–1.52 1.28 1.17–1.41
Stroke 1.19 1.14–1.23 1.21 1.12–1.30 1.18 1.12–1.23
Female sex 1.06 1.00–1.13 1.15 1.03–1.28
Smoking 1.06 1.02–1.11 1.13 1.06–1.22
Dyslipidemia 0.72 0.69–0.75 0.75 0.71–0.81 0.71 0.68–0.74
Obesity 0.83 0.79–0.86 0.79 0.71–0.89 0.84 0.80–0.89
Obstructive sleep apnea 0.83 0.79–0.86 0.81 0.74–0.88 0.85 0.79–0.91
Arterial hypertension 0.96 0.92–1.01 0.93 0.85–1.02 0.97 0.92–1.03
T2D 0.96 0.92–1.01 1.00 0.93–1.09 0.95 0.90–1.00
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Discussion
This ten-year observational nationwide cohort of 79,935 patients reports for the first time the outcomes of 
patients from the French National Health data and represents one of the largest European retrospective study 
on AAA  repair21–23.
The proportion of patients who had EVAR/ open repair was balanced (approximatively 0.6) and was similar to 
the practice observed in other European  countries21,22. Ruptured AAA were most often treated using open repair 
(96.2% of cases). A population-based study in Finland between 2000 and 2014 revealed similar results, with 1627 
treated with open repair over the 1687 ruptured AAA (96.4%). Several observational and multicenter randomized 
clinical trials have demonstrated improved outcomes after EVAR for ruptured AAA 4,24 and national trends in 
the United States confirmed that EVAR is increasingly used in the treatment of AAA  rupture25,26. Changes in the 
management of ruptured AAA are thus to be expected in France within the next decade.
The in-hospital mortality of patients operated during the first hospital stay for a non-ruptured AAA in France 
was 3.6%. A nationwide analysis of 84,631 patients in Germany reported comparable rate, with 3.3% of in-hospital 
mortality in patients operated for intact AAA 21. In case of aortic rupture, the in-hospital mortality during the 
first hospital stay for AAA repair was high (40%) and was concordant with other published  studies27,28.
The prevalence of diabetes (including type 1 and type 2) was 24.4%, which corresponds to a high range com-
pared to other cohorts previously  published17,18,29–31. In our cohort, the prevalence of diabetes was significantly 
lower in patients with ruptured AAA compared to non-ruptured. This is concordant with a meta-analysis of 11 
studies that showed that diabetes was associated with significantly lower prevalence/incidence of AAA rupture 
(OR/ HR = 0.77; CI95% = 0.63–0.95, P = 0.01)12. Nevertheless, we also found that the prevalence of the others 
cardiovascular and metabolic comorbidities (such as arterial hypertension, dyslipidemia, obesity, obstructive 
sleep apnea, smoking, congestive heart failure or past history of stroke) was significantly lower in patients with 
ruptured AAA compared to non-ruptured AAA. The paradoxical negative association observed in our study 
could be explained by a delay in the diagnosis of AAA in patients who did not have followed or known cardio-
vascular and metabolic comorbidities. It can be hypothesized that patients with comorbidities benefit from a 
closer follow-up and a screening of associated cardiovascular diseases. AAA in these patients may be discovered 
at earlier, asymptomatic and non-ruptured stage. On the other hand, it can be assumed that most of the patients 
who presented a rupture may have not been previously diagnosed for an AAA and may have not benefited from 
a systematic screening of cardiovascular comorbidities. It is thus possible that cardio-metabolic comorbidities 
may be underdiagnosed and underestimated in patients admitted for a ruptured AAA.
Interestingly, we found that in-hospital mortality during the first AAA repair was lower in diabetic patients 
compared to non-diabetic after AAA open repair for both ruptured and unruptured AAA. There was no sig-
nificant difference for EVAR. However, in-hospital total mortality was higher in diabetic patients treated with 
open repair for an unruptured AAA. This result is corroborated by a systematic review including 64 studies that 
investigated the association between diabetes and AAA 16. The authors found that diabetic patients showed lower 
survival rates at 2 to 5-year follow-up compared to non-diabetic  patients16.
Diabetic patients undergoing EVAR for unruptured AAA had also higher in-hospital total mortality com-
pared to non-diabetic. Similar results were observed from the EUROSTAR registry that included 6017 patients 
undergoing  EVAR17 were mortality was significantly higher in the diabetic population compared to non-diabetic 
patients (13% vs 10%, p < 0.039; OR = 1.27, CI95% = 1.01–1.59)17.
Taken together, our results suggest that in non-ruptured AAA treated with open repair and EVAR, the pres-
ence of diabetes is not associated with worsen immediate post-operative outcomes but it may impair survival 
on longer follow-up period. The survival analysis and results on long-term mortality showed a worse prognosis 
in patients with type 1 diabetes after both open repair and EVAR, while type 2 diabetes was not identified as 
a significant risk factor. Other cardiovascular or metabolic comorbidities including the presence of congestive 
heart failure, past history of stroke, or smoking were identified as risk factors of post-operative mortality. Other 
studies have also identified heart failure, ischemic heart disease, cerebrovascular disease and diabetes as risk fac-
tors of mortality following elective AAA  repair32,33. Nevertheless, we found in our cohort that the total mortality 
was significantly lower in patients presenting followed dyslipidemia, obesity, obstructive sleep apnea or smoking 
compared to those who did not have these comorbidities. Note that non-smokers were significantly older than 
smokers and could explain this result. Johal et al. recently aimed to examine patterns of 10-year survival after 
elective repair of unruptured AAA and investigated the survival among patients of different age and different 
co-morbidity score profiles from the English National Health  register34. The long-term survival patterns after 
elective open repair and EVAR for unruptured AAA varied markedly across patients with different age and co-
morbidity profiles. This underlines the complex impact of comorbidities on the post-operative outcomes and 
suggests that multiparametric predictive scores would be of interest.
The survival analysis after discharge from the first AAA repair revealed that aging, the presence of an aortic 
rupture, in-hospital readmission at 30 days, chronic respiratory and kidney diseases were predictive factors of 
post-operative mortality. These results are concordant with a meta-analysis including 45 studies investigating 
factors influencing survival following AAA  repair35. End stage renal disease, chronic obstructive pulmonary 
disease, age, cardiac failure, cerebrovascular diseases were associated with poor long-term survival. In our cohort, 
we found that in-hospital mortality was higher in patients who had open repair, and could be partially explained 
by the higher proportion of ruptured AAA. However, EVAR was associated with increased risk of long-term 
mortality after discharge from the hospital. Randomized clinical trials have suggested that EVAR was associated 
with early survival gain, while open repair showed similar or late survival  benefits36–39.
Limitations. This is a retrospective observational study based on electronic administrative database and the 
results may depend on the coding system. Nevertheless, the French National insurance information system uses 
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codes based on standardized definitions. Data are extracted by medical doctors and certified reviewers and the 
quality of the French National electronic health data is audited annually by experts. The medical treatments of 
patients were not available and the deaths occurring in the absence of hospitalization could not be recorded in 
the database. However, given the age of the population and the total mortality rate (21.3%), it can be assumed 
that most of the patients presenting a severe and potentially life-threatening disease may have been hospitalized.
Conclusion
This ten-year observational nationwide study investigated the outcomes of patients who underwent AAA repair 
in France between 2010–2019. Total in-hospital mortality over the 10-year study was 21.3% and 5.8% of deaths 
occurred during the first hospital stay for AAA repair. The presence of diabetes was significantly lower in patients 
with AAA rupture compared to patients with intact AAA. Our results suggested that the presence of diabetes 
may not worsen immediate post-operative mortality but it may impact survival on longer follow-up period. In 
multivariate analysis, type 1 diabetes was identified as a risk factor of post-operative mortality after discharge. 
This study highlights the complex association between diabetes and AAA and should encourage institutions to 
report long-term follow-up after AAA repair to better understand its impact.
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